Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/13/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. JNJ
6. PLTR
7. DMART:IN
8. HUM
9. KTOS
10. NVDA

Go back to Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business

Edgewise Therapeutics (EWTX) PT Raised to $52 at Wedbush

June 1, 2026 2:09 PM EDT

Wedbush analyst Laura Chico raised the price target on Edgewise Therapeutics (NASDAQ: EWTX) to $52.00 (from $46.00) while maintaining a Outperform rating.

The analyst comments "Remain Outperform rated on EWTX, new $52 target. EWTX reached a deal with Servier (not covered) to acquire all... More